Circulating tumor cells were first described in 1869 by Thomas Ashworth, an Australian pathologist who observed them in a peripheral blood sample taken from a patient with metastatic cancer. 1 They ...

Researchers working on blood-based cancer screening have reached a threshold that could change how early-stage tumors are ...

Serum tumor markers (STMs), including alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG), are currently used in management of patients with germ cell tumors (GCTs). STMs in a substantial ...

We conducted a systematic meta-analysis of 30 studies involving 3,287 patients with postoperative NSCLC to evaluate the diagnostic performance of ctDNA-based MRD testing for recurrence detection and ...

Earlier blood-test detection could help identify pancreatic cancer patients who need more aggressive treatment, an expert told Newsweek.

Please provide your email address to receive an email when new articles are posted on . Patients with small cell lung cancer who had higher levels of detectable ctDNA mutations at diagnosis had worse ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the release of a new clinical study demonstrating the significant prognostic value of its ...

Researchers identified a six-gene signature in microscopic colorectal cancer (CRC) liver metastases that may help predict ...

An implantable scaffold and magnetic probes capture circulating tumor cells directly in the bloodstream, eliminating over 90% of captured cells in rabbits and goats. (Nanowerk Spotlight) A single ...